|
CLGN Collplant Biotechnologies Ltd - ADR 1631487 |
| Balance Sheet |
|
Current Assets
|
$6,747,000.00 |
|
Assets
|
$10,785,000.00 |
|
Current Liabilities
|
$2,672,000.00 |
|
Liabilities
|
$4,704,000.00 |
|
Equity
|
$6,081,000.00 |
|
Shares Out
|
12803006.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-9,419,000.00 |
|
Investing Cash Flow
|
$-27,000.00 |
| Market Analysis |
Market Cap
|
$4,096,961.92 |
|
Price
|
$4.56 |
|
BVPS
|
0.48 |
|
PB
|
0.67 |
|
EPS
|
-0.94 |
|
PS
|
1.73 |
|
FCF
|
$-9,447,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:03 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:53 |
|
| Apr |
May |
Jun |
| 2026-03-26 |
-0.83 |
|
|
2026-05-29 |
-0.23 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-20 |
-0.23 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-26 |
-0.25 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CLGN documents filed with the SEC.
CLGN Filings
Clear
